يعرض 1 - 10 نتائج من 42 نتيجة بحث عن '"Leino, Teppo O."', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المساهمون: Divisions of Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, Drug Research Program, Pharmaceutical Design and Discovery group, Veterinary Biosciences, Faculty of Veterinary Medicine, Faculty of Pharmacy, Department of Pharmacology, Jari Yli-Kauhaluoma / Principal Investigator, Computational Adme, Henri Xhaard / Principal Investigator, Division of Pharmaceutical Biosciences, Erik Wallen / Principal Investigator, Medicinal Chemistry research group

    وصف الملف: application/pdf

    العلاقة: Leino , T O , Turku , A , Urvas , L , Adhikari , K , Oksanen , J , Steynen , Y , Yli-Kauhaluoma , J , Xhaard , H , Kukkonen , J P & Wallén , E A A 2023 , ' Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists ' , Bioorganic & Medicinal Chemistry , vol. 88-89 , 117325 . https://doi.org/10.1016/j.bmc.2023.117325Test; ORCID: /0000-0002-6989-1564/work/137437590; ORCID: /0000-0003-0370-7653/work/137437764; ORCID: /0000-0003-0959-7221/work/137438818; ORCID: /0000-0003-2582-7971/work/137440251; http://hdl.handle.net/10138/359559Test; c9572f10-7a1b-42fd-9f32-fe162591a425; 001001557400001

  3. 3
    دورية أكاديمية

    المساهمون: Divisions of Faculty of Pharmacy, PREP in neurodegenerative disorders, Division of Pharmaceutical Chemistry and Technology, Division of Pharmacology and Pharmacotherapy, Organismal and Evolutionary Biology Research Programme, Faculty of Pharmacy, Pharmaceutical Design and Discovery group, Drug Research Program, Erik Wallen / Principal Investigator, Medicinal Chemistry research group

    وصف الملف: application/pdf

    العلاقة: Kilpelainen , T P , Patsi , H T , Svarcbahs , R , Julku , U H , Eteläinen , T S , Cui , H , Auno , S , Sipari , N , Norrbacka , S , Leino , T O , Jäntti , M , Myöhänen , T T & Wallen , E A A 2023 , ' Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on alpha-Synuclein Mouse Models of Parkinson's Disease ' , Journal of Medicinal Chemistry , vol. 66 , no. 11 , pp. 7475-7496 . https://doi.org/10.1021/acs.jmedchem.3c00235Test; ORCID: /0000-0002-0786-2493/work/137858078; ORCID: /0000-0002-9277-6687/work/137863336; ORCID: /0000-0003-2582-7971/work/137863726; ORCID: /0000-0002-1312-9837/work/137864347; ORCID: /0000-0003-2931-6853/work/137864976; ORCID: /0000-0003-0802-2557/work/137865122; http://hdl.handle.net/10138/563197Test; 16a1b13f-44d5-4dbb-b1f4-a84fa0485c6f; 001005897700001

  4. 4
    دورية أكاديمية

    المساهمون: Terveyden Tutkimuksen Toimikunta, Helsinki Institute of Life Science, Helsingin Yliopisto, Business Finland, Sigrid Juselius Foundation

    المصدر: Journal of Medicinal Chemistry ; volume 66, issue 11, page 7475-7496 ; ISSN 0022-2623 1520-4804

  5. 5
    دورية أكاديمية

    وصف الملف: application/pdf; fulltext

    العلاقة: European Journal of Medicinal Chemistry; 237; 330800; Research Council of Finland; Suomen Akatemia; Leino, T. O., Sieger, P., Yli-Kauhaluoma, J., Wallén, E. A., & Kley, J. T. (2022). The azulene scaffold from a medicinal chemist's perspective : Physicochemical and in vitro parameters relevant for drug discovery. European Journal of Medicinal Chemistry , 237 , Article 114374. https://doi.org/10.1016/j.ejmech.2022.114374Test; CONVID_118852176; URN:NBN:fi:jyu-202204262374; http://urn.fi/URN:NBN:fi:jyu-202204262374Test

  6. 6
    دورية أكاديمية

    المساهمون: Faculty of Pharmacy, Pharmaceutical Design and Discovery group, Division of Pharmaceutical Chemistry and Technology, Drug Research Program, Jari Yli-Kauhaluoma / Principal Investigator, Jyrki Kukkonen / Principal Investigator, Veterinary Biochemistry and Cell Biology, Veterinary Biosciences, Departments of Faculty of Veterinary Medicine, Faculty of Veterinary Medicine, Department of Physiology, Medicum, Henri Xhaard / Principal Investigator, Erik Wallen / Principal Investigator, Medicinal Chemistry research group

    وصف الملف: application/pdf

    العلاقة: Leino , T O , Turku , A , Yli-Kauhaluoma , J T , Kukkonen , J P , Xhaard , H & Wallén , E A A 2018 , ' Azulene-based compounds for targeting orexin receptors ' , European Journal of Medicinal Chemistry , vol. 157 , pp. 88-100 . https://doi.org/10.1016/j.ejmech.2018.07.040Test; ORCID: /0000-0003-0370-7653/work/50286680; ORCID: /0000-0003-0959-7221/work/50289879; ORCID: /0000-0003-2582-7971/work/50290708; ORCID: /0000-0002-6989-1564/work/63349244; http://hdl.handle.net/10138/319069Test; be64b9c4-f27c-4b99-9902-88569234386b; 85050849346; 000447480000008

  7. 7
    دورية أكاديمية

    المساهمون: Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, Veterinary Biosciences, Departments of Faculty of Veterinary Medicine, Pharmaceutical Design and Discovery group, Medicum, Department of Physiology, Veterinary Biochemistry and Cell Biology, Henri Xhaard / Principal Investigator, Computational Adme, Drug Research Program, Erik Wallen / Principal Investigator, Jyrki Kukkonen / Principal Investigator, Medicinal Chemistry research group

    وصف الملف: application/pdf

    العلاقة: Santeri Suokas, Marja Peltola and Jouni Oksanen (Biochemistry and Cell Biology, Department of Veterinary Biosciences, University of Helsinki) are gratefully acknowledged for technical assistance with the experiments, and Kaj-Roger Hurme (Instrument Centre of Faculty of Agriculture and Forestry, University of Helsinki) and Raija Savolainen (Institute of Biotechnology, University of Helsinki) for all help with the liquid scintillation counting and luminescence measurements, respectively. This work was supported by the European Union (FP7-HEALTHproject GLORIA [# 602919]), the Magnus Ehrnrooth Foundation, the Finnish Cultural Foundation, the Orion Research Foundation, the Liv & Halsa Foundation, and the Doctoral Program in Drug Research of the University of Helsinki.; Rinne , M K , Leino , T O , Turku , A , Turunen , P M , Steynen , Y , Xhaard , H , Wallen , E A A & Kukkonen , J P 2018 , ' Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26 ' , European Journal of Pharmacology , vol. 837 , pp. 137-144 . https://doi.org/10.1016/j.ejphar.2018.09.003Test; ORCID: /0000-0003-0959-7221/work/49162309; ORCID: /0000-0003-2582-7971/work/49162603; ORCID: /0000-0002-3129-1678/work/49160715; ORCID: /0000-0002-6989-1564/work/63349243; ORCID: /0000-0003-3218-2841/work/68616121; http://hdl.handle.net/10138/305214Test; aff2e1b3-c4b3-4caf-a9e3-98c8277aa516; 85053081769; 000444963400016

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المساهمون: Faculty of Pharmacy, Pharmaceutical Design and Discovery group, Medicum, Veterinary Biosciences, Departments of Faculty of Veterinary Medicine, Faculty of Veterinary Medicine, Division of Pharmaceutical Chemistry and Technology, Henri Xhaard / Principal Investigator, Drug Research Program, Jyrki Kukkonen / Principal Investigator, Veterinary Biochemistry and Cell Biology, Department of Physiology, Erik Wallen / Principal Investigator, Medicinal Chemistry research group

    وصف الملف: application/pdf

    العلاقة: Karhu , L , Weisell , J , Turunen , P M , Leino , T O , Pätsi , H , Xhaard , H , Kukkonen , J P & Wallén , E A A 2018 , ' Stapled truncated orexin peptides as orexin receptor agonists ' , Peptides , vol. 102 , pp. 54-60 . https://doi.org/10.1016/j.peptides.2018.02.004Test; RIS: urn:47A3C83D5A70294343EAE7F9322ED5A3; ORCID: /0000-0003-2582-7971/work/44189377; ORCID: /0000-0001-6432-8580/work/44189445; ORCID: /0000-0002-3129-1678/work/44189234; ORCID: /0000-0002-6989-1564/work/63349261; http://hdl.handle.net/10138/234577Test; 342c7d94-0f56-473a-9ae0-178e813e1e17; 85042934582; 000427917500008

  10. 10
    دورية أكاديمية

    المساهمون: Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, Jari Yli-Kauhaluoma / Principal Investigator, Drug Discovery, Pharmaceutical Design and Discovery group, Drug Research Program, Medicinal Chemistry research group

    وصف الملف: application/pdf

    العلاقة: We thank Ms. Anna Keltikangas nee Takala for the synthesis assistance. This study was supported by the Academy of Finland (projects 264020 and 265481 to JYK). CLJ holds the Michael and Penny Feiwel Professorial Chair of Dermatology.; Keurulainen , L , Heiskari , M , Nenonen , S , Nasereddin , A , Kopelyanskiy , D , Leino , T O , Yli-Kauhaluoma , J , Jaffe , C L & Kiuru , P 2015 , ' Synthesis of carboxyimidamide-substituted benzo[c][1,2,5]oxadiazoles and their analogs, and evaluation of biological activity against Leishmania donovani ' , MedChemComm , vol. 6 , no. 9 , pp. 1673-1678 . https://doi.org/10.1039/c5md00119fTest; ORCID: /0000-0001-8528-7757/work/30218069; ORCID: /0000-0003-0370-7653/work/28760601; ORCID: /0000-0003-2582-7971/work/29942451; ORCID: /0000-0001-6084-684X/work/41128118; http://hdl.handle.net/10138/224652Test; 73e21bf2-65fd-4006-8e14-3f82da4f00a5; 84940939353; 000360639300012